chartexchange

Verrica Pharmaceuticals Reports Q3 2026 Revenue of $6.9M, Advances Clinical Trials (VRCA)

GuruFocus | Nov 13, 2026 3:56 AM EST

Related Stocks: VRCA ,

Read original article